Latest

• Genome-scale CRISPR screens identify PTGES3 as a direct modulator of AR function in advanced prostate cancer
• Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer
• Generalized Extreme Studentized Deviate (GESD) test to detect outliers in R
• Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
• An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression
• Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
• Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression
• Applications of Artificial Intelligence in Biotechnology and Medicine
• The genomic and epigenomic landscape of double-negative metastatic prostate cancer
• Beyond Reconstruction: What Leads to Satisfaction in Post-Disaster Recovery?
• The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
• Raunak Shrestha receives Todd Boehly - Prostate Cancer Foundation Young Investigator Award - 2022
• Predicting Cancer Drug TARGETS - TreAtment Response GlmnET Signatures
• An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
• Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability
• Autoantibody landscape in patients with advanced prostate cancer
• Identification of Conserved Evolutionary Trajectories in Tumors
• Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma
• Group segmentation and heterogeneity in the choice of cooking fuels in post-earthquake Nepal
• यस्तो अवस्थामा आउँछ आरडीटी नेगेटिभ, पीसीआर पोजिटिभ
• Y-box Binding Protein-1 is Crucial in Acquired Drug Resistance Development in Metastatic Clear-Cell Renal Cell Carcinoma
• Identification of Predictive Gene Signature to Guide Precision Oncology of Clear-Cell Renal Cell Carcinoma
• Pathway and network analysis of more than 2,500 whole cancer genomes
• BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
• Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks
• Visualization of Bibliography in my PhD Thesis
• Computational prioritization of cancer driver genes for precision oncology
• High-throughput detection of RNA processing in bacteria
• Deep Genomic Signature for early metastasis prediction in Prostate Cancer
• Ultra High-Dimensional Nonlinear Feature Selection for Big Biological Data
• HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology
• BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer
• Visualize and cluster one-mode projection of a bi-partite graph
• Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
• A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines
• HIT'nDRIVE: Multi-driver gene prioritization based on hitting time
• Analysis of KatG Ser315Thr Mutation in Multidrug Resistant Mycobacterium tuberculosis and SLC11A1 Polymorphism in Multidrug Resistance Tuberculosis in Central Development Region of Nepal Using PCR-RFLP Technique: A Pilot Study